1. Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy
   Sepideh Mirzaei et al, 2021, Life Sciences CrossRef
2. Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
   Alba Loras et al, 2021, Cancers CrossRef
3. Apoptosis Resistance in Solid Tumours: A Potential Therapeutic Target in Gastric Carcinoma?
   William A. Butterworth et al, 2024, CrossRef
4. It's time to die: BH3 mimetics in solid tumors
   Sarah Kehr et al, 2021, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
5. Bcl-xL: A Focus on Melanoma Pathobiology
   Anna Maria Lucianò et al, 2021, International Journal of Molecular Sciences CrossRef
6. Comprehensive functional evaluation of head and neck squamous cell carcinoma with BH3-profiling demonstrates apoptotic competency and therapeutic efficacy of BH3-mimetics
   Daniel Li et al, 2024, Oral Oncology CrossRef
7. Role of the lncRNA ABHD11-AS1 in the tumorigenesis and progression of epithelial ovarian cancer through targeted regulation of RhoC
   Dan-Dan Wu et al, 2017, Molecular Cancer CrossRef
8. Sertindole, an Antipsychotic Drug, Curbs the STAT3/BCL-xL Axis to Elicit Human Bladder Cancer Cell Apoptosis In Vitro
   Chao-Yu Hsu et al, 2023, International Journal of Molecular Sciences CrossRef
9. Epigenetic therapy in urologic cancers: an update on clinical trials
   Inês Faleiro et al, 2017, Oncotarget CrossRef